Alpha tau medical ltd DRTS.US 總覽分析
美股醫療保健
(DRTS 無簡報檔)
DRTS 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分低，若以價值投資為目標且有長期投資部位，需要嚴格執行自己的出場計畫來減持部位
DRTS 近期報酬表現
1.03%
Alpha tau medical ltd
0.38%
同產業平均
-0.07%
S&P500
與 DRTS 同產業的標的表現
- CHRO Channel therapeutics corp價值 -趨勢 2 分波段 2 分籌碼 1 分股利 1 分查看更多
DRTS 公司資訊
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.